Zheyu Wang, Biometrics Section Publications Officer

The Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) is accepting applications to fund pilot and feasibility studies focused on the discovery, validation, or qualification of chronic kidney disease (CKD) biomarkers. As part of this program, applications proposing the development and/or evaluation of new statistical methods relevant to biomarker research specifically related to CKD biomarkers will be accepted.

CKD BioCon was established by the National Institute of Diabetes and Digestive and Kidney Diseases to promote the discovery, evaluation, and validation of biomarkers to advance CKD research.

The deadline for preliminary applications is March 16.

The full funding opportunity announcement can be found at the Chronic Kidney Disease Biomarkers Consortium website.